Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic vaccination against tuberculosis

D B Lowrie1, C L Silva, R E Tascon

  • 1National Institute for Medical Research, London, UK.

Springer Seminars in Immunopathology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at sqrt[s_{NN}]=200  GeV [Phys. Rev. Lett. 116, 122301 (2016)].

Physical review letters·2025
Same author

Disentangling Centrality Bias and Final-State Effects in the Production of High-p_{T} Neutral Pions Using Direct Photon in d+Au Collisions at sqrt[s_{NN}]=200  GeV.

Physical review letters·2025
Same author

On the origin of low-valent uranium oxidation state.

Nature communications·2024
Same author

Measurement of Direct-Photon Cross Section and Double-Helicity Asymmetry at sqrt[s]=510  GeV in p[over →]+p[over →] Collisions.

Physical review letters·2023
Same author

Accumulation and decomposition of cultural residues of Theobroma grandiflorum, Paullinia cupana, Bixa orellana and forest in the southern region of Amazonas.

Brazilian journal of biology = Revista brasleira de biologia·2023
Same author

Probing Gluon Spin-Momentum Correlations in Transversely Polarized Protons through Midrapidity Isolated Direct Photons in p^{↑}+p Collisions at sqrt[s]=200  GeV.

Physical review letters·2021
Same journal

Antibody and complement-dependent viral neutralization.

Springer seminars in immunopathology·2020
Same journal

Antibody mediated complement dependent lysis of virus infected cells.

Springer seminars in immunopathology·2020
Same journal

Activating and inhibitory FcgammaRs in autoimmune disorders.

Springer seminars in immunopathology·2006
Same journal

Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.

Springer seminars in immunopathology·2006
Same journal

Fcepsilon- and Fcgamma-receptor signaling in diseases.

Springer seminars in immunopathology·2006
Same journal

Fc gamma receptors and cancer.

Springer seminars in immunopathology·2006
See all related articles

New tuberculosis vaccines targeting secreted and stress proteins show promise. DNA vaccines effectively generate protective T cells, offering a potential alternative to BCG for long-lasting immunity.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Tuberculosis (TB) remains a significant global health threat, necessitating novel vaccine strategies beyond the current BCG vaccine.
  • Existing TB vaccines have limitations in efficacy and duration of protection.

Purpose of the Study:

  • To identify effective antigens for a new tuberculosis vaccine.
  • To evaluate the potential of DNA vaccination for inducing protective immunity against TB.

Main Methods:

  • Administering diverse protein antigens with adjuvants or as DNA vaccines in animal models.
  • Analyzing bacterial multiplication arrest and decline as measures of protection.
  • Characterizing T cell responses, including interferon-gamma production and cytotoxic activity.
  • Conducting adoptive T cell transfer experiments.

Related Experiment Videos

Main Results:

  • Protein antigens, particularly secreted and stress proteins (e.g., Ag85, ESAT-6, hsp65, hsp70), induced high levels of protective immunity in animal models.
  • Vaccination strategies targeting antigens from both actively multiplying and growth-inhibited bacteria are crucial.
  • Protection is mediated by antigen-specific cytotoxic T cells producing interferon-gamma.
  • DNA vaccination effectively generated these protective T cells and may provide long-lasting immunity.

Conclusions:

  • Novel TB vaccines can be developed using specific protein antigens, with DNA vaccination showing particular promise.
  • The identified antigens are not species-specific, preserving their utility for diagnostic applications.
  • Antigen-specific cytotoxic T cells are key mediators of vaccine-induced protection against tuberculosis.